Ignite Creation Date:
2025-12-26 @ 11:11 AM
Ignite Modification Date:
2026-02-28 @ 8:36 AM
Study NCT ID:
NCT03895528
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2021-04-15
First Post:
2019-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lonafarnib for Patients With Hutchinson-Gilford Progeria Syndrome or Progeroid Laminopathy
Sponsor:
Eiger BioPharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EIG-EAP-LNF-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None